Ernexa Therapeutics Inc.: Form 8-K, filed Dec 9, 2013
Filed with the SEC on Dec 9, 2013 and accepted by EDGAR at Dec 9, 2013, 15:11 ET.
Items reported
- Item 4.01 Change of auditor
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001019687-13-004756. Last ingested by Listed: Nov 6, 2026, 17:52 ET. Listed shows no prices and gives no investment advice.